 |
Contingency analysis of CMS's proposals
to alter Medicare reimbursements for infusion therapies |
|
In states that turned Medicaid over
to HMOs, will restricted formularies drive out open ones? |
|
Effects of patent extension lobbying
upon practitioners in a specified therapeutic
category |
|
Effects of a bundling exclusivity agreement
upon specialists |
